Regulatory & Legal

Herbalife's new podcast with Paralympian Palak Kohli reveals a deeper trend: how corporate content is fueling a new ecosystem for para-athletes in India.

Chemical giant Nouryon is doubling down on Brazil, building a new innovation hub to co-create sustainable beauty and cleaning products for a booming market.

Commercial Metals Company's fourth responsibility award isn't just PR. We decode how its deep ESG integration is a strategic moat in a changing market.

A Texas battery plant is online in record time thanks to a Chinese robotics firm. Discover the 'factory in a box' strategy transforming industrial deployment.

A novel drug for heart failure shows promising safety and efficacy data, potentially disrupting a multi-billion dollar market and validating a key investor's strategy.

Hexagon Purus erases a $12.9M debt in its Panasonic battery deal but gives up lucrative US tax credits, a move securing its supply chain at a high cost.

Denali Therapeutics raises $200M to advance its brain-penetrating drugs, betting big on its pipeline despite short-term market jitters.

Following stellar clinical data, Terns Pharmaceuticals' upsized $650M offering signals massive investor confidence and funds its push to disrupt the CML market.

A 1.01 Tbps cyberattack was just a skirmish in a wider war. See how advanced AI and massive defenses are the new front line against digital extortion.

CEO Adrian Mendes' major buy-in signals deep confidence as Perimeter Medical AI navigates FDA approval for its game-changing cancer surgery technology.

After a 94% stock collapse, 707 Cayman asks shareholders to approve a risky financing deal. Is this a necessary move for survival or a costly dilution?

Beyond bureaucracy, a federal push for bilingual services aims to dismantle linguistic barriers, impacting health equity for minority communities across Canada.

A regulatory filing from Balyasny Asset Management reveals intense investor activity as a bidding war for narcolepsy drugmaker Avadel heats up.

Abundia Global Impact Group and Alterra Energy are building a major plastics-to-fuel facility, a bold move to reshape the Gulf Coast's energy landscape.

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

A $2.4B tech acquisition seems distant from healthcare, but Qualcomm's move to buy Alphawave is building the essential AI infrastructure for medicine's future.

An Atlanta clinic's top award highlights a market shift toward minimally invasive fibroid treatment and a crucial fight for health equity in women's care.

Canada's sweeping new law tackles femicide, coercive control, and online predators, aiming to shift the justice system's focus to victim protection.

Junior miner Walker Lane Resources seeks a strategic partner after permitting woes stalled its 2025 plans. Can it unlock its Nevada gold potential?